Arogya Meditech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 31-10-2024
- Paid Up Capital ₹ 0.10 M
as on 31-10-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -76.15%
(FY 2023)
- Profit -85.32%
(FY 2023)
- Ebitda -72.07%
(FY 2023)
- Net Worth 14.06%
(FY 2023)
- Total Assets -67.19%
(FY 2023)
About Arogya Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devender Jain and Anuj Sharma serve as directors at the Company.
- CIN/LLPIN
U51909HR2020PTC089329
- Company No.
089329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Arogya Meditech Private Limited offer?
Arogya Meditech Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Ventilator Parts & Consumables, Infusion Syringes & Supplies, Catheter.
Who are the key members and board of directors at Arogya Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devender Jain  | Whole-Time Director | 15-Sep-2020 | Current |
| Anuj Sharma | Director | 23-Nov-2020 | Current |
Financial Performance of Arogya Meditech.
Arogya Meditech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 76.15% decrease. The company also saw a substantial fall in profitability, with a 85.32% decrease in profit. The company's net worth Soared by an impressive increase of 14.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arogya Meditech?
In 2023, Arogya Meditech had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Connectplus Evehicle Solutions Private LimitedActive 2 years 1 monthDevender Jain is a mutual person
- Arogya Retail Private LimitedActive 2 years 6 months
Devender Jain and Anuj Sharma are mutual person
- Treidcom India Private LimitedActive 1 year 4 months
Devender Jain and Anuj Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arogya Meditech?
Arogya Meditech has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arogya Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arogya Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
